Study found time-restricted feeding improves cognitive function in Alzheimer’s disease rats, suggesting neuroprotective effects.
Introduction Alzheimer’s disease (AD), a major neurodegenerative disorder, is characterized by progressive cognitive decline and the accumulation of amyloid‐beta and tau proteins in the brain. Intermittent fasting (IF) is being explored as a dietary intervention to mitigate AD‐related effects, possibly by modulating factors such as reelin and α ‐synuclein, which are involved in synaptic function and AD pathology. Methods The study included six groups of rats: Ctrl, Ctrl.ADF, Ctrl.TRF, AD, AD.TRF, and AD.ADF. AD was induced by bilateral ICV injections of 5 μL Aβ. To prove fasting, blood glucose levels were assessed with a glucometer. Memory and learning were assessed using the Morris Water Maze (MWM) test, and hippocampal reelin and α ‐synuclein concentrations were quantified via ELISA. Electrophysiological recordings were analyzed using eProbe software. Results TRF was more effective than ADF in improving cognitive function in AD rats, as indicated by a significant increase in TSGQ [ F (5,40) = 5.590, p < 0.01] and swimming speed [ F (3,21) = 114.3, p < 0.01], along with a significant reduction in latency time and path length ( p < 0.001). Both TRF and ADF significantly increased reelin concentration and neuronal firing rate ( p < 0.01), whereas only TRF led to a significant decrease in α ‐synuclein levels. Discussion These findings suggest that TRF may enhance spatial memory and reduce α ‐synuclein accumulation in AD rats, possibly through mechanisms associated with synaptic plasticity and neuroprotection.
No takes yet. Share an insight, caveat, or question.
Maleki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: